Stay updated on Durvalumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.

Latest updates to the Durvalumab in Cervical Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded an explanatory note that PubMed publications are automatically filled from PubMed and may not relate to the study; updated the page revision to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the government funding notice indicating that information may not be up to date due to funding lapses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check27 days agoChange DetectedAdded Tainan, Taiwan, 704 as a study site and removed Tainan City, Taiwan, 704 from the locations. This updates the geographic coverage of trial sites for potential participants.SummaryDifference0.0%

- Check34 days agoChange DetectedAdded Gurgaon, India, 122001 as a study site location and removed Gūrgaon, India, 122001. This reflects updated spelling and site listing in the study's locations.SummaryDifference0.0%

- Check41 days agoChange DetectedEnrollment updated to 770. Primary Completion Date updated to 2022-01-20 and Study Completion Date updated to 2023-07-03 in the Study Details.SummaryDifference0.2%

- Check64 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to Durvalumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.